Skip to content

Eqwal Stomacare

Active
Private limited companyfounded 2012active for 13 yearsHerman Teirlinckstraat 15, 9041 Gent, BelgiumKBO/BCE: BE 0849.873.517
Summary

Eqwal Stomacare has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €233,891. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 59% of 12,404 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Specialist medical practice NACE 86220
1 site
Size
€2.7mtotal assets 2025
Staff
7.6 FTE
Equity
€1.2m
Profit
€233,891
Turnover not published (abbreviated format)
Financial health
70 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.7%
Structure
Parent
FINICOMA · 100%
Accounts 8 days early3 of 13 deeds read
Why 70raises risk1 change of registered office in 24 months1 of the last 3 latelowers riskFigures for financial year 2025 (filed 24-04-2026)Liquidity: current ratio 1.80, cash €353,071Show the evidence

Checked score

Score 2025
70 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 61% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 70+5
equity 45.5% of total assets
Liquidity 39+2
short-term debt 54.5% · cash 13.2%
Profitability 80-3
return on assets 8.7%
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,189 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024lowest value 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.3%▲ +0.1 percentage points vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.5%▲ +0.2 percentage points vs 04-2025 06-2025: 0.3%▼ -0.2 percentage points vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.7%▲ +0.4 percentage points vs 10-2025 12-2025: 0.8%▲ +0.1 percentage points vs 11-2025 01-2026: 0.8%● unchanged vs 12-2025 02-2026: 1.0%▲ +0.2 percentage points vs 01-2026 03-2026: 1.0%● unchanged vs 02-2026 04-2026: 1.2%▲ +0.2 percentage points vs 03-2026highest value 05-2026: 0.7%▼ -0.5 percentage points vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 0.7%● unchanged vs 07-2026 09-2026: 0.7%● unchanged vs 08-2026 10-2026: 0.7%● unchanged vs 09-2026
Credit of up to €85,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.8, compared with 1.59 in 2024, above the usual 1.5; short-term debt: 54.5% and cash: 13.2% of total assets), but 54.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 60% on solvency, 36% on liquidity, 71% on profitability and 76% on growth.

The bankruptcy probability was computed on 13-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed 24-04-2026)
NBB · annual accounts
raises risk · 1 of the last 3 late
NBB · filings
lowers risk · Liquidity: current ratio 1.80, cash €353,071
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 22-04-2026, 8 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
8 days early
2024
6 days late
2023
56 days late
2022
3 days early
2021
18 days early
2020
4 days late
2019
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 2 May (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end13-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Registered officeRegistered-office move · Power of…
  3. Amendment of the articles · NameRegistered office clause · Name…

Key points

  • Positive: Among the best 10% on net resultsector median €28,321 · 12,392 companies €233,891 View
  • Controlled by FINICOMAultimately: Ovalie Développement 4 SAS 100% View
  • Positive: 7 profitable years in a rowprofit 2025: €233,891 7 years View

By topic

Financials

Financial year
2025
Total assets
€2.7m
Profit
€233,891
Solvency
45.5%
Total assets▲ 7.6%
Net result
20192025
Go to Financials

Timeline

Events
20
Since
2015
Next accounts
by 30-04-2027
  1. 30-09-2025Equity above €1m
  2. 26-06-2025Reappointment: RSM InterAudit SRL (statutory auditor)
  3. 06-05-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded
18-10-2012
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.